New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
18:21 EDTANFI, GTIV, NUAN, TSLA, WMBOn The Fly: After Hours Movers
UP AFTER EARNINGS: Amira Nature Foods (ANFI), up 28.36% after fourth quarter results top expectations. ALSO HIGHER: Gentiva Health Services (GTIV) up 4.36% after Kindred Healthcare (KND) announced a $14.50 tender offer for Gentiva... Nuance (NUAN), up 1.6%... Tesla (TSLA), up fractionally after NY allows the company to keep five currently licensed retail locations. LOWER: Williams (WMB), down 1% after filing to sell $3B of common stock.
News For ANFI;GTIV;NUAN;TSLA;WMB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 9, 2014
08:46 EDTGTIVKindred sees 'significant,' 'achievable' synergies from Gentiva deal
Kindred (KND) says it expects to issue in aggregate $620M-$720M of equity to maintain reasonable leverage. Says will issue Gentiva (GTIV) shareholders $200M in Kindred stock as part of purchase consideration, plans to raise $200M-$300M in equity and/or mandatory convertible securities between announcement and close. Says integration teams assembled, ready to be deployed immediately upon closing. Comments from slides that will be presented on Kindred's conference call discussing the proposed acquisition of Gentiva.
08:45 EDTGTIVGentiva volatility low into being acquired by Kindred for $1.8B
Subscribe for More Information
08:38 EDTGTIVKindred volatility flat into acquiring Gentiva for $1.8B
Subscribe for More Information
08:27 EDTGTIVKindred sees Gentiva deal immediately and significantly accretive
Kindred (KND) expects the acquisition of Gentiva (GTIV) will be immediately and significantly accretive to earnings and operating cash flows, exclusive of transaction and integration costs. Kindred expects the acquisition to be approximately 40c-60c accretive to pro forma earnings, and pro forma operating cash flows of $350 million to $400 million, both on a run rate basis, once Gentiva is fully integrated and expected synergies are fully realized in the second full year following the closing. On this same basis, following the combined company’s expected annual maintenance capital expenditures of $120 million to $130 million, Kindred expects pro forma cash flows of $230 million to $270 million. Kindred has identified approximately $70 million of annual cost and operating synergies and expects to achieve the full run rate within two years of closing, of which approximately $35 million is expected to be achieved in the first year following the closing. Kindred expects the majority of cost synergies to be achieved through combining information technology functions, merging supply chains and eliminating redundant public company expenses. In addition, Kindred expects to realize revenue synergies that will improve patient care transitions and choice, and drive volume growth as a result of cross-selling across the combined service platform. Kindred expects annual run rate revenue synergies of more than $60 million over time, with approximately $20 million to $30 million achievable in the first full year following the closing.
08:26 EDTGTIVKindred Healthcare says combined company to operate in 47 states
Subscribe for More Information
08:25 EDTGTIVKindred to acquire Gentiva for $19.50 per share in cash and stock, or $1.8B
Kindred Healthcare (KND) and Gentiva Health Services (GTIV) announced that the companies have entered into a definitive merger agreement under which Kindred will acquire all of the outstanding shares of Gentiva common stock for $19.50 per share in a combination of cash and stock. The agreement was unanimously approved by the boards of directors of both companies. Under the terms of the agreement, Gentiva shareholders will receive $14.50 per share in cash and $5.00 of Kindred common stock. The transaction is valued at $1.8 billion, including the assumption of net debt. The companies expect the closing of the transaction to occur in the first quarter of 2015. The combined company will: Employ approximately 109,000 individuals, making it the 78th largest private employer and the 4th largest healthcare employer in the United States; Deliver pro forma annual revenues of approximately $7.1 billion; and Generate pro forma operating income, including expected cost synergies, of $1.0 billion. Paul J. Diaz, CEO of Kindred, said, “Over the last eight weeks, we undertook a robust due diligence process and worked closely and constructively with our counterparts at Gentiva to better understand their operations, financial results and outlook. This process confirmed the compelling strategic rationale and industrial logic of this combination, as well as our belief that this transaction is in the best interests of both companies and our respective shareholders, patients, employees and business partners." Kindred has obtained committed financing from Citi and J.P. Morgan in connection with the pending transaction. Subject to market and other conditions, the Company expects to finance the acquisition of Gentiva and associated costs through the issuance of $200 million to $300 million of common stock and mandatory convertible equity securities and $1.3 billion to $1.4 billion of unsecured notes prior to the closing of the acquisition. The Company expects to fund the remaining amounts through its existing line of credit. Following completion of the transaction, Kindred expects to have approximately 85 million fully diluted shares outstanding, comprised primarily of approximately 64 million shares outstanding today, approximately 10 million shares to be issued to Gentiva as part of the transaction consideration, and approximately nine million to 12 million shares associated with the expected offering of common stock and mandatory convertible equity securities. The Gentiva acquisition is subject to certain conditions, including the approval by the stockholders of Gentiva. Kindred and Gentiva have already received clearance for the transaction under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
08:23 EDTGTIVKindred to acquire Gentiva for $19.50 per share in cash and stock
Subscribe for More Information
06:48 EDTTSLATesla added to U.S. Focus List at Credit Suisse
Subscribe for More Information
October 8, 2014
18:31 EDTNUANOn The Fly: After Hours Movers
UP AFTER EARNINGS: Ruby Tuesday (RT), up 19.6%... Exar (EXAR), up 13.7% after reporting second quarter revenue guidance... Alcoa (AA), up 2.2%. ALSO HIGHER: Nuance (NUAN), up 2.5% following rumors that Carl Icahn will recommend that Apple (AAPL) buy the company... GrubHub (GRUB), up just under 1% after being initiated with a Buy at CRT Capital. DOWN AFTER EARNINGS: Kofax (KFX), down 20.1% after reporting first quarter revenue and fiscal 2015 revenue guidance below analyst estimates... ARC Group (ARCW), down 17%... E2open (EOPN), down 8.9%. ALSO LOWER: Gap (GPS), down 7.6% following September same store sales data and CEO transition... AMD (AMD), down 7% after announcing CEO transition.
16:26 EDTNUANOn The Fly: Closing Wrap
Subscribe for More Information
16:01 EDTTSLAOptions Update; October 8, 2014
iPath S&P 500 VIX Short-Term Futures down 2.73 to 29.51. Option volume leaders: AAPL TSLA TWTR AMZN FB NFLX PBR AA CLF GILD according to Track Data.
15:12 EDTNUANNuance October calls active amid speculation Icahn speculation
Subscribe for More Information
15:05 EDTNUANRumor: Nuance moves off lows amid Icahn speculation
Subscribe for More Information
10:00 EDTTSLAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:54 EDTTSLATesla volatility increases into October 9 announcement
Tesla October weekly call option implied volatility is at 67, October is at 45, November is at 54, December is at 48; compared to its 26-week average of 46 according to Track Data, suggesting large price movement into an announcement scheduled for October 9.
06:07 EDTTSLATesla initiated with a Neutral at Tigress Financial
Tigress Financial started shares of Tesla with a Neutral rating saying that while it is "extremely enthusiastic" about the company's product offering and growth potential, it has concerns about "inherent industry obstacles" and the current valuation.
October 7, 2014
16:00 EDTTSLAOptions Update; October 7, 2014
iPath S&P 500 VIX Short-Term Futures up 2.16 to 32.24 Option volume leaders: AAPL TSLA TWTR AMZN FB VZ AA HTZ NFLX PBR according to Track Data.
11:15 EDTTSLATesla expected to unveil all-wheel drive Model S, Re/code reports
Subscribe for More Information
09:36 EDTTSLAActive equity options trading on open
Subscribe for More Information
06:35 EDTTSLAPanasonic says Tesla plant stake worth 'tens of billions' of yen, Reuters says
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use